Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Explore when to make changes to your spending plan and how to rebalance categories so you stay aligned with goals and cash flow.
23,566 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Tesla faces a pivotal Q2 print as shares struggle in 2026. While deliveries rose, investors will be watching margins,...
Mercadolibre hits $14.5 billion in annual sales, marking a major milestone for Latin America's e-commerce and fintech...
As tax day approaches, millions await refunds. This guide on refund tracker explained: what to know outlines timing, ...
Medtronic stock popped today after the company topped earnings expectations and revenue forecasts. This article expla...
A deep dive into the hidden costs behind a record wealth year linked to branding, properties, and regulatory exposure...
Geopolitical tensions in the Middle East drive a sharp jump in U.S. gasoline prices, rattling consumer budgets and br...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...
Factory construction and investment are rising rapidly, fueling talk of a manufacturing renaissance. Yet a wide gap b...
Three iShares ETFs have jumped more than 100% in 2026, led by chip-rich South Korea and Taiwan. This article breaks d...
Trump’s fury spain working as Washington weighs new trade moves against Madrid, drawing a sharp response from Spain a...
As kimball (ke) 2026 earnings unfold, investors care most about revenue growth, margin stability, and cash flow. This...